Stay updated on TQ05105 Tablets in Refractory aGVHD Clinical Trial
Sign up to get notified when there's something new on the TQ05105 Tablets in Refractory aGVHD Clinical Trial page.

Latest updates to the TQ05105 Tablets in Refractory aGVHD Clinical Trial page
- Check6 days agoChange DetectedFooter now shows Revision: v3.5.4 instead of v3.5.3, reflecting a new release version of the record history page. This update appears to be a metadata update rather than a modification to the study information.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new revision v3.5.3 was added to the study's record history, indicating an update to the trial record. The previous revision v3.5.2 was removed from the history view.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision v3.5.2 was added to the record history and revision v3.5.0 was removed.SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision entry v3.5.0 was added to the record history, replacing the previous v3.4.3.SummaryDifference0.1%

- Check70 days agoChange DetectedA new latest revision, v3.4.3, is added to the history and the previous revision v3.4.2 is removed.SummaryDifference0.1%

- Check99 days agoChange DetectedA new Revision: v3.4.2 was added to the record history. The government-funding/operating-status notice and the previous Revision: v3.4.1 entry were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

Stay in the know with updates to TQ05105 Tablets in Refractory aGVHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TQ05105 Tablets in Refractory aGVHD Clinical Trial page.